ENTHERA
Enthera is a new Italian biotech start-up whose mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway. Its name comes from the crasis of the terms entero (referring to the intestine) and therapy. Enthera was founded by BiovelocITA in October 2016 in collaboration with the scientists: Prof. Paolo Fiorina and Dr. Francesca D’Addio.
ENTHERA
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2016-10-01
Address:
Milano, Lombardia, Italy
Country:
Italy
Website Url:
http://www.entherapharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
+39 02 3456778
Total Funding:
39 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
Roche Venture Fund
Roche Venture Fund investment in Series A - Enthera
Indaco Venture Partners
Indaco Venture Partners investment in Series A - Enthera
Arepo Fiduciaria
Arepo Fiduciaria investment in Series A - Enthera
Sofinnova Partners
Sofinnova Partners investment in Series A - Enthera
Banor SIM
Banor SIM investment in Series A - Enthera
JDRF T1D Fund
JDRF T1D Fund investment in Series A - Enthera
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Enthera
Sofinnova Partners
Sofinnova Partners investment in Seed Round - Enthera
Official Site Inspections
http://www.entherapharmaceuticals.com Semrush global rank: 7.72 M Semrush visits lastest month: 440
- Host name: carnage.evtel.com
- IP address: 18.156.43.197
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Enthera"
Enthera – First-in-class therapeutics for auto-immune …
Enthera Pharmaceuticals Will Present Preclinical Data on Ent001, an Anti-TMEM219 Antibody in Development For The Treatment Of Ulcerative Colitis at The European Crohn’s And Colitis Organization 2024 Annual MeetingSee details»
About Us – Enthera
Novel therapeutic concept. Our pioneering approach is to target IGFBP3/TMEM219, a novel stem cell apoptosis pathway involved in the development and progression of several autoimmune …See details»
Enthera - Crunchbase Company Profile & Funding
Enthera is a new Italian biotech start-up whose mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other …See details»
Enthera Pharmaceuticals - LinkedIn
Enthera Pharmaceuticals | 2,814 followers on LinkedIn. First-in-class therapeutics for autoimmune disorders | We develop first-in-class biologics for several underserved autoimmune conditions. Our ...See details»
Enthera Pharmaceuticals - Craft
Enthera Pharmaceuticals has 5 employees across 3 locations and $32.84 m in total funding,. See insights on Enthera Pharmaceuticals including office locations, competitors, revenue, …See details»
Overview, News & Similar companies - ZoomInfo.com
Mar 7, 2023 Enthera Pharmaceuticals contact info: Phone number: +39 23456778 Website: www.entherapharmaceuticals.com What does Enthera Pharmaceuticals do? Enthera Srl, …See details»
Enthera Pharmaceuticals: Contact Details and Business Profile
Enthera Pharmaceuticals is a Pharmaceutical Manufacturing company located in IT with 21 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Enthera Pharmaceuticals Appoints Lisa M. Olson as CEO and …
Jan 23, 2024 Enthera Pharmaceuticals Lisa M. Olson Ph.D., CEO [email protected]. Trophic Communications Valeria Fisher or Veronika Máté …See details»
Enthera Pharmaceuticals — Sofinnova Partners
Www.entherapharmaceuticals.com. Graziano Seghezzi. Managing Partner, Sofinnova Partners. Related News. 23 January, 2024 Enthera Pharmaceuticals appoints Lisa M. Olson as CEO …See details»
Enthera Company Profile 2024: Valuation, Funding & Investors
Enthera General Information Description. Developer of biotherapeutics intended to treat auto-immune disorders. The company's pipelined products target pathways involved in cell …See details»
Enthera Pharmaceuticals Initiates Phase 1 Clinical Trial with Lead ...
Mar 7, 2023 Enthera Pharmaceuticals Aled Williams, CEO [email protected] Trophic Communications Valeria Fisher or Veronika Máté +49 175 8041816 or +49 160 …See details»
Management Team – Enthera - entherapharmaceuticals.com
This website uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the website does not require the user’s consent.See details»
Team – Enthera
This website uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the website does not require the user’s consent.See details»
Enthera Pharmaceuticals appoints Lisa M. Olson as CEO and …
Related News. 31 October, 2024 TechBio startup Cure51 selects 10x Genomics Visium HD for new drug discovery initiative; 30 October, 2024 Noema Pharma announces first patients …See details»
Enthera Pharmaceuticals Raises €28 Million in Series A Financing …
Jul 28, 2020 The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research, with an exclusive focus on supporting the best commercial …See details»
Media Centre – Enthera
Feb 20, 2024 Enthera Pharmaceuticals (“Enthera”), a clinical-stage biotech company developing first-in-class antibody therapeutics targeting the Insulin Growth Factor Binding Protein (IGFBP) …See details»
Enthera Pharmaceuticals - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Enthera Pharmaceuticals Appoints Aled Williams as Chief Executive ...
Milan, Italy, 4 May 2022 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel …See details»
Enthera Pharmaceuticals Extends Series A Financing, Raising a …
Jan 28, 2021 Enthera Srl Giovanni Amabile, CEO T: +39 (0)2 3456778 E: [email protected] Instinctif Partners (media enquiries) Dr Christelle …See details»